Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Luca Zammataro

Showing results (1-10 of 57) with videos related to

Pageof 6
Sort By:
F1000Research|February 7, 2025
CINNAMON-GUI: Revolutionizing Pap Smear Analysis with CNN-Based Digital Pathology Image ClassificationLuca Zammataro
Journal of Theoretical Biology|November 8, 2006
Embryonic cleavage modeling as a computational approach to sphere packing problemLuca Zammataro, Guido Serini, Todd Rowland, et al.
BMC Bioinformatics|February 26, 2014
AnnotateGenomicRegions: a web applicationLuca Zammataro, Rita DeMolfetta, Gabriele Bucci, et al.
Biochimica Et Biophysica Acta. Reviews on Cancer|August 17, 2021
Protein domain-based approaches for the identification and prioritization of therapeutically actionable cancer variantsElisabetta Grillo, Cosetta Ravelli, Michela Corsini, et al.
Biochimica Et Biophysica Acta. Molecular Basis of Disease|November 26, 2021
Novel potential oncogenic and druggable mutations of FGFRs recur in the kinase domain across cancer typesElisabetta Grillo, Cosetta Ravelli, Michela Corsini, et al.
Gynecologic Oncology Reports|June 28, 2018
Binimetinib (MEK162) in recurrent low-grade serous ovarian cancer resistant to chemotherapy and hormonal treatmentChanhee Han, Stefania Bellone, Luca Zammataro, et al.
Cytokine & Growth Factor Reviews|December 17, 2009
The chemokine system in cancer biology and therapyAlberto Mantovani, Benedetta Savino, Massimo Locati, et al.
Journal of Cell Science|May 11, 2013
Pbx1 restrains myeloid maturation while preserving lymphoid potential in hematopoietic progenitorsFrancesca Ficara, Laura Crisafulli, Chenwei Lin, et al.
Cancer Letters|October 9, 2020
A novel variant of VEGFR2 identified by a pan-cancer screening of recurrent somatic mutations in the catalytic domain of tyrosine kinase receptors enhances tumor growth and metastasisElisabetta Grillo, Michela Corsini, Cosetta Ravelli, et al.
Blood|July 28, 2010
Gremlin is a novel agonist of the major proangiogenic receptor VEGFR2Stefania Mitola, Cosetta Ravelli, Emanuela Moroni, et al.
Pageof 6

Showing results (1-10 of 57) with videos related to

Sort By:
Pageof 6
F1000Research|February 7, 2025
CINNAMON-GUI: Revolutionizing Pap Smear Analysis with CNN-Based Digital Pathology Image ClassificationLuca Zammataro
Journal of Theoretical Biology|November 8, 2006
Embryonic cleavage modeling as a computational approach to sphere packing problemLuca Zammataro, Guido Serini, Todd Rowland, et al.
BMC Bioinformatics|February 26, 2014
AnnotateGenomicRegions: a web applicationLuca Zammataro, Rita DeMolfetta, Gabriele Bucci, et al.
Biochimica Et Biophysica Acta. Reviews on Cancer|August 17, 2021
Protein domain-based approaches for the identification and prioritization of therapeutically actionable cancer variantsElisabetta Grillo, Cosetta Ravelli, Michela Corsini, et al.
Biochimica Et Biophysica Acta. Molecular Basis of Disease|November 26, 2021
Novel potential oncogenic and druggable mutations of FGFRs recur in the kinase domain across cancer typesElisabetta Grillo, Cosetta Ravelli, Michela Corsini, et al.
Gynecologic Oncology Reports|June 28, 2018
Binimetinib (MEK162) in recurrent low-grade serous ovarian cancer resistant to chemotherapy and hormonal treatmentChanhee Han, Stefania Bellone, Luca Zammataro, et al.
Cytokine & Growth Factor Reviews|December 17, 2009
The chemokine system in cancer biology and therapyAlberto Mantovani, Benedetta Savino, Massimo Locati, et al.
Journal of Cell Science|May 11, 2013
Pbx1 restrains myeloid maturation while preserving lymphoid potential in hematopoietic progenitorsFrancesca Ficara, Laura Crisafulli, Chenwei Lin, et al.
Cancer Letters|October 9, 2020
A novel variant of VEGFR2 identified by a pan-cancer screening of recurrent somatic mutations in the catalytic domain of tyrosine kinase receptors enhances tumor growth and metastasisElisabetta Grillo, Michela Corsini, Cosetta Ravelli, et al.
Blood|July 28, 2010
Gremlin is a novel agonist of the major proangiogenic receptor VEGFR2Stefania Mitola, Cosetta Ravelli, Emanuela Moroni, et al.
Pageof 6